2007
DOI: 10.1055/s-2007-976226
|View full text |Cite
|
Sign up to set email alerts
|

In-vitro-Inhibition von humanen Linsenepithelzellen (hLEZ) mittels eines pharmakologisch modifizierten Kapselspannringes zur Prävention der Cataracta secundaria

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2008
2008
2008
2008

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Mibefradil containing micro particles were prepared by modifying a solvent evaporation procedure using ethyl acetate as dispersing solvent [23]. These micro capsules released the active agent with a daily average of 7.5 mg/l during a period of 50 days [24,25]. The micro particles were coupled on the PMMA (polymethyl methacrylate) surface of the capsular tension ring (Micromod Partikeltechnologie GmbH) [25] which contain 38 mg Mibefradil per gram.…”
Section: Materials and Methodologymentioning
confidence: 99%
“…Mibefradil containing micro particles were prepared by modifying a solvent evaporation procedure using ethyl acetate as dispersing solvent [23]. These micro capsules released the active agent with a daily average of 7.5 mg/l during a period of 50 days [24,25]. The micro particles were coupled on the PMMA (polymethyl methacrylate) surface of the capsular tension ring (Micromod Partikeltechnologie GmbH) [25] which contain 38 mg Mibefradil per gram.…”
Section: Materials and Methodologymentioning
confidence: 99%